Crosssectional Assessment of Bone Mass Density in Adults with Hepatitis B Virus and Hepatitis C Virus Infection
Open Access
- 25 March 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 5069
Abstract
Osteoporosis is one of the major complications in chronic hepatitis B virus (HBV) and hepatitis C (HCV) infection. However, few studies had examined the relationship between hepatic viral infection with bone loss. Our aim was to investigate the association between hepatic viral infection with bone mineral density (BMD) in a cross-sectional study. Participants who attended the health examinations at the Tri-Service General Hospital (TSGH), Taiwan, were enrolled in the study. Diagnosis of viral hepatitis was confirmed by the serum viral markers of hepatitis B surface antigen (HBsAg) and anti-HCV, and BMD measurement was performed by the bone densitometry. Subjects were divided into four groups by the presence of viral markers. The association between hepatic viral infection and BMD was examined by a multivariate linear regression model. HBV infection was inversely associated with BMD after full adjusting withβvalues of −0.17 (95% CI: −0.29, −0.05) (p < 0.05). The relationship remained significant in males (β = −0.16, 95% CI = −0.31, −0.01) (p < 0.05). In subjects with body mass index less than 30 HBV infection was associated with reduced BMD (β = −0.16, 95% CI = −0.29, −0.02) (p < 0.05). However, HCV infection was only associated with an increase in BMD in patients with BMI less than 30 (β = 0.17, 95% CI = 0.21, 0.32) (p < 0.05). Chronic HBV infection was significantly associated with reduced BMD in males. The impact of viral hepatitis on bone health deserves further investigation for the potential pathophysiological mechanisms.Keywords
This publication has 38 references indexed in Scilit:
- The Insulin-Like Growth Factor System in BoneEndocrinology and Metabolism Clinics of North America, 2012
- Association of circulating insulin‐like growth factor 1 with hepatocellular carcinoma: one cross‐sectional correlation studyJournal of Clinical Laboratory Analysis, 2010
- Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis CScandinavian Journal of Gastroenterology, 2009
- Isoform of Fibronectin Mediates Bone Loss in Patients With Primary Biliary Cirrhosis by Suppressing Bone FormationJournal of Bone and Mineral Research, 2008
- Epidemiology, etiology, and diagnosis of osteoporosisAmerican Journal of Obstetrics and Gynecology, 2006
- Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project)Journal of Medical Virology, 2005
- Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2αA) Is Inhibited by Tumor Necrosis Factor-αJournal of Biological Chemistry, 2002
- Global surveillance and control of hepatitis CJournal of Viral Hepatitis, 1999
- Osteoporosis in Chronic Liver Disease: Pathogenesis, Risk Factors, and ManagementDigestive Diseases, 1994
- Effect of Vitamin D Intake on Seasonal Variations in Parathyroid Hormone Secretion in Postmenopausal WomenNew England Journal of Medicine, 1989